4.6 Article

Characterization of hMTr1, a Human Cap1 2′-O-Ribose Methyltransferase

Journal

JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 285, Issue 43, Pages 33037-33044

Publisher

AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/jbc.M110.155283

Keywords

-

Funding

  1. Canadian Institutes of Health Research [MOP-79385]
  2. Fonds de Recherche en Sante du Quebec
  3. Howard Hughes Medical Institute [55005604]
  4. National Science Support Project [PBZMNiSW-07/I/2007]

Ask authors/readers for more resources

Cellular eukaryotic mRNAs are capped at their 5` ends with a 7-methylguanosine nucleotide, a structural feature that has been shown to be important for conferring mRNA stability, stimulating mRNA biogenesis (splicing, poly(A) addition, nucleocytoplasmic transport), and increasing translational efficiency. Whereas yeast mRNAs have no additional modifications to the cap, called cap0, higher eukaryotes are methylated at the 2`-O-ribose of the first or the first and second transcribed nucleotides, called cap1 and cap2, respectively. In the present study, we identify the methyltransferase responsible for cap1 formation in human cells, which we call hMTr1 (also known as FTSJD2 and ISG95). We show in vitro that hMTr1 catalyzes specific methylation of the 2`-O-ribose of the first nucleotide of a capped RNA transcript. Using si RNA-mediated knockdown of hMTr1 in HeLa cells, we demonstrate that hMTr1 is responsible for cap1 formation in vivo.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available